Investors / United States / Narya
Narya
Venture capital · Columbus, OH, United States · North America
Narya is a concentrated early-stage venture capital firm that partners with founders building companies in large markets the market has left unsolved. It invests early and concentrates its capital, staying involved with founders for years.
Invests inAI & Machine LearningHealthcare & Biotech
In its own wordsmedicarespacedefensebiotechmanufacturingprofessional services
Your fit with Narya
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsNarya lists 17 checked portfolio companies on its own site and is named in 10 funding rounds. Its most frequent entry is Series B, 38% of the companies with a known first round. Its largest themes are AI & Machine Learning (35%), Healthcare & Biotech (31%) and Fintech (12%). 93% of its companies are based in United States. It invests most often alongside Founders Fund, Anthemis and Drive Capital.
Counts come from funding rounds that name Narya, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Narya's whole history. Rounds on record name 8 companies; its own site lists 17. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 13% |
| Series A | 25% |
| Series B | 38% |
| Growth | 25% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 1 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 4 | 0 |
| '26 | 5 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 44th | 17 companies |
| Recent activity | 86th | 5 rounds in 12 months |
| Early stage | 55th | 13% of entries at pre-seed or seed |
| Evidence | 99th | 41% of companies confirmed by a round |
| Sector focus | 63th | 35% in its largest sector |
| Reach | 42th | 2 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| AI & Machine Learning | 35% | 18% |
| Healthcare & Biotech | 31% | 15% |
| Fintech | 12% | 12% |
| Industrial & Manufacturing | 8% | 7% |
| Education | 4% | 7% |
| Real Estate & Construction | 4% | 3% |
| Cybersecurity | 4% | 4% |
| Legal & Compliance | 4% | 2% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Founders Fund | 3 |
| Anthemis | 2 |
| Drive Capital | 2 |
| Fifth Down Capital | 2 |
| General Catalyst | 2 |
| T1D Fund | 2 |
| XYZ | 2 |
| Y Combinator | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers17100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherCompare Narya head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
from public registers and its siteRecent portfolio activity
when companies last raised with Narya| Date | Company | Stage |
|---|---|---|
| 10 Jun 2026 | Series C+ | |
| 29 May 2026 | Seed | |
| 28 Apr 2026 | Series C+ | |
| 9 Apr 2026 | Series C+ | |
| 8 Jan 2026 | Series A | |
| 16 Oct 2025 | Series B | |
| 10 Sept 2025 | Series B | |
| 30 Apr 2025 | Series C+ |
Round details for Narya
Amounts, full round histories and every co-investor in Narya's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
17 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| AcreTrader allows individuals to invest in farmland | AI & Machine LearningAI & Machine Learning | Jan 2022Series B | Page + round | |
| The company helps older Americans navigate retirement and provides personalized Medicare help from licensed advisors. | Healthcare & BiotechFintech | Apr 2025Series A · 2 rounds | Page + round | |
| Atomic Industries manufactures products using mold making and AI-native operations | Industrial & ManufacturingAI & Machine Learning | Portfolio page | ||
| Beren Therapeutics develops medicines to address the root cause of diseases | Healthcare & Biotech | Jun 2026Series C+ | Page + round | |
| Hallow develops and offers a prayer and meditation app | Healthcare & BiotechEducation | Portfolio page | ||
| Kodex provides software for managing law enforcement data requests | CybersecurityLegal & Compliance | Portfolio page | ||
| Kriya Therapeutics is building a new generation of durable medicines designed to be one-time treatments for chronic diseases | Healthcare & Biotech | Portfolio page | ||
| Kriya Therapeutics is developing durable medicines for chronic diseases | Healthcare & Biotech | Sept 2025Series B | Funding round | |
| Branch provides home, auto, and umbrella insurance to its customers | FintechHealthcare & Biotech | Portfolio page | ||
| Peptilogics is a surgical therapeutics company that develops a novel anti-biofilm drug to cure and prevent medical device-related infections. | Healthcare & Biotech | Oct 2025Series B | Page + round | |
| The company provides artificial intelligence solutions to mining companies to increase production, reduce downtime, and manage safety risks. | AI & Machine LearningIndustrial & Manufacturing | Portfolio page | ||
| Reprogram Biosciences is developing a groundbreaking immunotherapy approach that transforms cancer cells into immune-like cell types to combat solid tumors. | Healthcare & Biotech | May 2026Seed | Page + round | |
| Portfolio page | ||||
| Strive Asset Management offers various exchange-traded funds (ETFs) for investment purposes. | Fintech | Portfolio page | ||
| True Anomaly designs and builds spacecraft, software, and payloads for space superiority | AI & Machine LearningAI & Machine Learning | Apr 2025Series C+ · 2 rounds | Page + round | |
| Valinor builds and acquires mission-critical technologies to fill gaps in defense and government systems. | AI & Machine LearningAI & Machine Learning | Jan 2026Series A | Page + round | |
| Valuebase provides data cleaning and valuation services to assessment offices | Real Estate & ConstructionAI & Machine Learning | Portfolio page |
About this data
site last read 12 Nov 2026- Site
- naryavc.com
- Last read
- 12 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 11 Jan 2022
- Companies checked
- 17
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Narya's profile as data
Pull Narya's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/naryavc.com
# also
GET /v1/firms/naryavc.com/portfolio
GET /v1/firms/naryavc.com/coinvestors
GET /v1/firms/naryavc.com/news